Literature DB >> 18375754

Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.

Wolfgang Hoyer1, Caroline Grönwall, Andreas Jonsson, Stefan Ståhl, Torleif Härd.   

Abstract

According to the amyloid hypothesis, the pathogenesis of Alzheimer's disease is triggered by the oligomerization and aggregation of the amyloid-beta (Abeta) peptide into protein plaques. Formation of the potentially toxic oligomeric and fibrillar Abeta assemblies is accompanied by a conformational change toward a high content of beta-structure. Here, we report the solution structure of Abeta(1-40) in complex with the phage-display selected affibody protein Z(Abeta3), a binding protein of nanomolar affinity. Bound Abeta(1-40) features a beta-hairpin comprising residues 17-36, providing the first high-resolution structure of Abeta in beta conformation. The positions of the secondary structure elements strongly resemble those observed for fibrillar Abeta. Z(Abeta3) stabilizes the beta-sheet by extending it intermolecularly and by burying both of the mostly nonpolar faces of the Abeta hairpin within a large hydrophobic tunnel-like cavity. Consequently, Z(Abeta3) acts as a stoichiometric inhibitor of Abeta fibrillation. The selected Abeta conformation allows us to suggest a structural mechanism for amyloid formation based on soluble oligomeric hairpin intermediates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375754      PMCID: PMC2278213          DOI: 10.1073/pnas.0711731105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  An affibody in complex with a target protein: structure and coupled folding.

Authors:  Elisabet Wahlberg; Christofer Lendel; Magnus Helgstrand; Peter Allard; Vildan Dincbas-Renqvist; Anders Hedqvist; Helena Berglund; Per-Ake Nygren; Torleif Härd
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.

Authors:  Gernot Habicht; Christian Haupt; Ralf P Friedrich; Peter Hortschansky; Carsten Sachse; Jessica Meinhardt; Karin Wieligmann; Gerald P Gellermann; Michael Brodhun; Jürgen Götz; Karl-Jürgen Halbhuber; Christoph Röcken; Uwe Horn; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

3.  Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain.

Authors:  K Nord; E Gunneriusson; J Ringdahl; S Ståhl; M Uhlén; P A Nygren
Journal:  Nat Biotechnol       Date:  1997-08       Impact factor: 54.908

4.  Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and nucleic acids.

Authors:  J Kuszewski; A M Gronenborn; G M Clore
Journal:  J Magn Reson       Date:  1997-03       Impact factor: 2.229

5.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

Authors:  B Solomon; R Koppel; D Frankel; E Hanan-Aharon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Arrest of beta-amyloid fibril formation by a pentapeptide ligand.

Authors:  L O Tjernberg; J Näslund; F Lindqvist; J Johansson; A R Karlström; J Thyberg; L Terenius; C Nordstedt
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

8.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

Authors:  J Deisenhofer
Journal:  Biochemistry       Date:  1981-04-28       Impact factor: 3.162

Review 9.  Strategies for disease modification in Alzheimer's disease.

Authors:  Martin Citron
Journal:  Nat Rev Neurosci       Date:  2004-09       Impact factor: 34.870

10.  Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.

Authors:  Liming Hou; Haiyan Shao; Yongbo Zhang; Hua Li; Nanda K Menon; Elizabeth B Neuhaus; John M Brewer; In-Ja L Byeon; Dale G Ray; Michael P Vitek; Takashi Iwashita; Ronald A Makula; Alan B Przybyla; Michael G Zagorski
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

View more
  137 in total

1.  Dynamics of amyloid β fibrils revealed by solid-state NMR.

Authors:  Holger A Scheidt; Isabel Morgado; Sven Rothemund; Daniel Huster
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

2.  Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay.

Authors:  Yi-Jiong Zhang; Jing-Ming Shi; Cai-Juan Bai; Han Wang; Hai-Yun Li; Yi Wu; Shang-Rong Ji
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

3.  Toxic fibrillar oligomers of amyloid-β have cross-β structure.

Authors:  James C Stroud; Cong Liu; Poh K Teng; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

4.  N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors:  Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

5.  Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.

Authors:  Buyong Ma; Ruth Nussinov
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 6.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

7.  Mechanical resistance in unstructured proteins.

Authors:  Sigurður Ægir Jónsson; Simon Mitternacht; Anders Irbäck
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

8.  The off-rate of monomers dissociating from amyloid-β protofibrils.

Authors:  Clara S R Grüning; Stefan Klinker; Martin Wolff; Mario Schneider; Küpra Toksöz; Antonia N Klein; Luitgard Nagel-Steger; Dieter Willbold; Wolfgang Hoyer
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

9.  Out-of-Register Parallel β-Sheets and Antiparallel β-Sheets Coexist in 150-kDa Oligomers Formed by Amyloid-β(1-42).

Authors:  Yuan Gao; Cong Guo; Jens O Watzlawik; Peter S Randolph; Elizabeth J Lee; Danting Huang; Scott M Stagg; Huan-Xiang Zhou; Terrone L Rosenberry; Anant K Paravastu
Journal:  J Mol Biol       Date:  2020-05-26       Impact factor: 5.469

10.  Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.

Authors:  Moustafa Algamal; Julijana Milojevic; Naeimeh Jafari; William Zhang; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.